Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Randomised placebo-controlled study of the effect of paracetamol on asthma severity in adults.

Ioannides SJ, Williams M, Jefferies S, Perrin K, Weatherall M, Siebers R, Crane J, Patel M, Travers J, Shirtcliffe P, Beasley R.

BMJ Open. 2014 Feb 12;4(2):e004324. doi: 10.1136/bmjopen-2013-004324.

2.

Diagnosing asthma in general practice with portable exhaled nitric oxide measurement--results of a prospective diagnostic study: FENO < or = 16 ppb better than FENO < or =12 ppb to rule out mild and moderate to severe asthma [added].

Schneider A, Tilemann L, Schermer T, Gindner L, Laux G, Szecsenyi J, Meyer FJ.

Respir Res. 2009 Mar 3;10:15. doi: 10.1186/1465-9921-10-15. Erratum in: Respir Res. 2009;10: 64 doi:10.1186/1465-9921-10-64.

3.

Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma.

van Rensen EL, Straathof KC, Veselic-Charvat MA, Zwinderman AH, Bel EH, Sterk PJ.

Thorax. 1999 May;54(5):403-8.

4.

Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group.

FitzGerald JM, Chapman KR, Della Cioppa G, Stubbing D, Fairbarn MS, Till MD, Brambilla R.

J Allergy Clin Immunol. 1999 Mar;103(3 Pt 1):427-35.

PMID:
10069876
6.

Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.

Lee DK, Fardon TC, Bates CE, Haggart K, McFarlane LC, Lipworth BJ.

Chest. 2005 Mar;127(3):851-60.

PMID:
15764767
7.

Effect of prasugrel in patients with asthma: results of PRINA, a randomized, double-blind, placebo-controlled, cross-over study.

Lussana F, Di Marco F, Terraneo S, Parati M, Razzari C, Scavone M, Femia EA, Moro A, Centanni S, Cattaneo M.

J Thromb Haemost. 2015 Jan;13(1):136-41. doi: 10.1111/jth.12779. Epub 2014 Dec 16.

8.

Exhaled nitric oxide and bronchial reactivity during and after inhaled beclomethasone in mild asthma.

Silkoff PE, McClean PA, Slutsky AS, Caramori M, Chapman KR, Gutierrez C, Zamel N.

J Asthma. 1998;35(6):473-9.

PMID:
9751064
9.

Association between asthma control and bronchial hyperresponsiveness and airways inflammation: a cross-sectional study in daily practice.

Quaedvlieg V, Sele J, Henket M, Louis R.

Clin Exp Allergy. 2009 Dec;39(12):1822-9. doi: 10.1111/j.1365-2222.2009.03332.x. Epub 2009 Oct 8.

10.
11.

Regular formoterol treatment in mild asthma. Effect on bronchial responsiveness during and after treatment.

Yates DH, Sussman HS, Shaw MJ, Barnes PJ, Chung KF.

Am J Respir Crit Care Med. 1995 Oct;152(4 Pt 1):1170-4.

PMID:
7551366
12.

Airway calibre as a confounder in interpreting bronchial responsiveness in asthma.

Dirksen A, Madsen F, Engel T, Frølund L, Heinig JH, Mosbech H.

Thorax. 1992 Sep;47(9):702-6.

13.

Time-dependent effects of inhaled corticosteroids on lung function, bronchial hyperresponsiveness, and airway inflammation in asthma.

Mehta V, Stokes JR, Berro A, Romero FA, Casale TB.

Ann Allergy Asthma Immunol. 2009 Jul;103(1):31-7. doi: 10.1016/S1081-1206(10)60140-8.

PMID:
19663124
14.

Concordance between bronchial hyperresponsiveness, fractional exhaled nitric oxide, and asthma control in children.

Thomas B, Chay OM, Allen JC Jr, Chiang AS, Pugalenthi A, Goh A, Wong P, Teo AH, Tan SG, Teoh OH.

Pediatr Pulmonol. 2016 Oct;51(10):1004-1009. doi: 10.1002/ppul.23426. Epub 2016 Apr 13.

PMID:
27074221
15.

Aerobic training decreases bronchial hyperresponsiveness and systemic inflammation in patients with moderate or severe asthma: a randomised controlled trial.

França-Pinto A, Mendes FA, de Carvalho-Pinto RM, Agondi RC, Cukier A, Stelmach R, Saraiva-Romanholo BM, Kalil J, Martins MA, Giavina-Bianchi P, Carvalho CR.

Thorax. 2015 Aug;70(8):732-9. doi: 10.1136/thoraxjnl-2014-206070. Epub 2015 Jun 10.

PMID:
26063507
16.

Effects of a PAF antagonist, Y-24180, on bronchial hyperresponsiveness in patients with asthma.

Hozawa S, Haruta Y, Ishioka S, Yamakido M.

Am J Respir Crit Care Med. 1995 Oct;152(4 Pt 1):1198-202.

PMID:
7551370
17.

Comparison of mannitol and methacholine to predict exercise-induced bronchoconstriction and a clinical diagnosis of asthma.

Anderson SD, Charlton B, Weiler JM, Nichols S, Spector SL, Pearlman DS; A305 Study Group.

Respir Res. 2009 Jan 23;10:4. doi: 10.1186/1465-9921-10-4.

18.

Single and short-term dosing effects of levocetirizine on adenosine monophosphate bronchoprovocation in atopic asthma.

Lee DK, Gray RD, Wilson AM, Robb FM, Soutar PC, Lipworth BJ.

Br J Clin Pharmacol. 2004 Jul;58(1):34-9.

19.

Effect of a leukotriene antagonist, ONO-1078, on bronchial hyperresponsiveness in patients with asthma.

Fujimura M, Sakamoto S, Kamio Y, Matsuda T.

Respir Med. 1993 Feb;87(2):133-8.

PMID:
8497683
20.

Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.

Rosenthal RR, Busse WW, Kemp JP, Baker JW, Kalberg C, Emmett A, Rickard KA.

Chest. 1999 Sep;116(3):595-602.

PMID:
10492259

Supplemental Content

Support Center